Intraperitoneal Taxol (paclitaxel) in the management of ovarian cancer.

Annals of oncology : official journal of the European Society for Medical Oncology / ESMO

Volumn 5 Suppl 6, Issue , 1994, Pages

  Markman, M ^a   Francis, P ^a   Rowinsky, E ^a   Hakes, T ^a   Reichman, B ^a   Jones, W ^a   Lewis Jr , J L ^a   Rubin, S ^a   Curtin, J ^a   Barakat, R ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; DIPHENHYDRAMINE; PACLITAXEL; RANITIDINE;

ARTICLE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DRUG ADMINISTRATION; FEMALE; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; NEUTROPENIA; OVARY TUMOR; PHASE 1 CLINICAL TRIAL; PREMEDICATION; TREATMENT OUTCOME;

DEXAMETHASONE; DIPHENHYDRAMINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INJECTIONS, INTRAPERITONEAL; NEUTROPENIA; OVARIAN NEOPLASMS; PACLITAXEL; PREMEDICATION; RANITIDINE; TREATMENT OUTCOME;

EID: 0028724864     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)